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THE biological effects induced by the polycycic hydrocarbons have been
extensively studied in many species and attempts have been made to correlate
these effects with the metabolism of the hydrocarbon. To this end investigations
ofanumber ofthemhave been made andfromexistingdatasummarisedbyYoung
(1950) and Boyland (1950) it would appear that several rather broad conclusions
can be drawn.
1. The non-carcinogenic hydrocarbons as represented by naphthalene,
anthracene and phenanthrene are metabolised to a variety of water soluble
products which are excreted in the urine. These metabolic end products consist of
phenols and the allied dihydroxy-dihydro compounds both free and conjugated.
In addition the urine contains a substance which regenerates the parent hydro-
carbon on heating the urine with acid andinthe case ofnaphthalene this precursor
has been identified as the glucuronide of 1: 2-dihydro-1-naphthol (Boyland and
Solomons, 1955).
2. The carcinogenic hydrocarbons as represented by 1: 2-benzanthracene
and chrysene (weak carcinogens), and 1: 2: 5: 6-dibenzanthracene, 3: 4-
benzpyrene and 9: 10-dimethyl-1: 2-benzanthracene are metabolised to a
variety of excretion products which appear mainly in the faeces, but to a certain
extent in the urine, as the free phenols and quinones. Further degradation
products have been identified for 1: 2:5: 6-dibenzanthracene (Heidelberger
and Wiest, 1951; Bhargava, Hadler and Heidelberger, 1955) and in the case of
3: 4-benzpyrene tissue intermediates have been isolated but not identified
(Weigert and Mottram, 1943 and 1946). These intermediates readily revert to
the fully aromatic benzpyrenoid state and by analogy with the non-carcinogenic
hydrocarbons a dihydroxy-dihydro structure has been postulated for them.
The essential differences therefore between the metabolic end products of
the non-carcinogenic and the carcinogenic hydrocarbons would appear to be:
(1) The preponderance of free phenols and quinones as major excretion
products of the carcinogenic members. This could possibly be explained on the
basis of unstable dihydroxy-dihydro intermediates. The theoretical chemist
Pullman (1954) has indeed calculated from resonance energy considerations that
the diols ofthe carcinogenic hydrocarbons should be more susceptible to dehydra-
tion than the diols of the non-carcinogenic members.
(2) The apparent absence of conjugation amongst the carcinogenic members
and
(3) the formation of an acid-labile hydrocarbon precursor from the non-
carcinogenic members.
These conclusions, however, are based upon the behaviour of a relatively
small cross-section of the polycyclic hydrocarbons and it was with the idea of
extending this field that this investigation was started.K. H. HARPER
The hydrocarbon pyrene appeared to be particularly suitable as an example
of a relatively large molecule for which no positive carcinogenic activity has been
reported.
The metabolism of pyrene had peviously been investigated by Chalmers
and Peacock (1941) in the fowl and they reported the excretion in the bile of a
derivative which fluoresced blue under ultra-violet light. They did not identify
it but its solvent and chromatographic behaviour indicated an acidic nature.
Elson, Goulden and Warren (1945), investigating the urine after the intra-
peritoneal injection of large doses of a number of hydrocarbons in the rat,
reported relatively large increases in the levels of ethereal sulphate, neutral
sulphur and glucuronic acid together with a fall in inorganic sulphate after the
injection of pyrene.
Thus excretion of metabolic products in both urine and faeces was indicated.
MATERIALS AND METHODS
The pyrene was prepared for injection as an aqueous dispersion of two
concentrations, 1 mg. per c.c. for intravenous and 10 mg. per c.c. for intra-
peritoneal injection.
The animals used were mice of RIII strain and rats of Wistar strain. Each
mouse received an intravenous dose of 0.5 mg. or an intraperitoneal dose of
10 mg. Each rat received an intravenous dose of 1 mg. or an intraperitoneal
dose of 50 mg. Throughout the experiment the animals were housed in metabolism
cages from which independent collections of urine and faeces were made.
The following reference compounds were prepared by the methods ofVollmann
Becker, Corell and Streeck (1937):
3-hydroxypyrene, pyrene-3: 8-quinone, pyrene-3: 10-quinone, 3: 10-dihy-
droxypyrene and 3: 8-dihydroxypyrene.
The following physical and chemical data of the reference compounds was
used to establish the identity or non-identity of the metabolites:
3-Hydroxypyrene (I). (1) Colourless zone on alumina from benzene fluores-
cing blue-violet in ultra-violet light.
(2) Absorption spectrum in ethyl alcohol (Fig. 1): maxima at 242, 257,
268, 278, 348, 366 and 386 m.,u.
(3) Absorption spectrum of the derived 3-methoxypyrene in ethyl alcohol
(Fig. 2): maxima at 241, 255, 266, 278, 335, 346, 350, 362, 373, 382. m.,.
Pyrene-3: O10-quinone (II).-(1) Red zone on alumina from benzene, deep
yellow solution in alcohol turning dark red on the addition of sodium hydroxide
solution.
(2) Disappearance of colour and appearance of the bright blue fluorescence
and the absorption spectrum of 3: 10-dihydroxypyrene on either reduction
with sodium hydrosulphite or warming an alcoholic solution of the quinone
with a few drops of concentrated hydrochloric acid.
(3) Absorption spectrum in ethyl alcohol.
Pyrene-3: 8-quinone (III).-(1) Yellow zone on alumina from benzene,
yellow solution in alcohol turning red on the addition of sodium hydroxide
solution.
(2) Disappearance of colour and appearance of the bright blue fluorescence
and absorption spectrum of 3: 8-dihydroxypyrene on either reduction with
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sodium hydrosulphite or warming an alcoholic solution of the quinone with a
few drops of concentrated hydrochloric acid.
(3) Absorption spectrum in ethyl alcohol.
3: 10-Dihydroxypyrene (IV) (not isolated in pure state).-(1) Colourless
solution in alcohol with an intense blue fluorescence in ultra-violet light.
(2) Yellow solution in alcohol and sodium hydroxide with an intense green
fluorescence in ultra-violet light.
(3) Formation of the yellow colour of pyrene-3: 10-quinone on addition of
sodium hypochlorite solution.
(4) Conversion to pyrene-3: O10-quinone on chromatography on alumina from
benzene.
FIG. 1.-Absorption spectra in ethyl alcohol.
3-hydroxypyrene (lower scale) - - - -phenol from rat urine.
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FIG. 2.-Absorption spectra in ethyl alcohol.
3-methoxypyrene (upper scale) - --- methylated phenol from rat urine.
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FIGa. 3.-Absorption spectra in ethyl alcohol.
3: 10-dihydroxypyrene - - - - phenol from hydrolysed rat urine.
(5) Absorption spectrum in ethyl alcohol (Fig. 3): maxima at 240-244,
278, 353, m./,. (possibly contaminated with trace of 3: 8-dihydroxypyrene).
3: 8-Dihydroxypyrene (V).-(1) Colourless solution in alcohol with an intense
blue fluorescence in ultra-violet light.
(2) Yellow solution in alcohol and sodium hydroxide with an intense green
fluorescence in ultra-violet light.
(3) Formation of the yellow colour of pyrene-3: 8-quinone on addition of
sodium hypochlorite solution.
(4) Conversion to pyrene-3: 8-quinone on chromatography on alumina from
benzene.
(5) Absorption spectrum in ethyl alcohol (Fig. 4): maxima at 245, 267, 278,
336, 352, 380, 401, m./t.
Faeces.-The faeces were collected daily, homogenised in a small volume of
water and extracted with 90 per cent acetone. After removal ofthe acetone under
reduced pressure the aqueous residue was extracted with benzene which was then
dried over sodium sulphate prior to chromatography on alumina.
Urine.-The urine was extracted successively with ether at pH 7 and then at
pH 2. In both cases initial extraction was carried out by shaking in the cold
followed by continuous Soxhlet extraction. By this procedure it was hoped to
minimise any temperature effect as previous experiments with the hydroxy-
anthracenes and 4'-hydroxy-1: 2-benzanthracene had shown that considerable
destructionofphenolicmaterial couldtakeplaceduringprolongedSoxhletextraction
procedures. The ether extracts were dried over sodium sulphate, the ether
removed under nitrogen and the brown oily residues extracted with benzene.
The benzene extracts were then chromatographed on alumina.
The urine after extraction still possessed a very strong blue-violet fluorescence
under ultra-violet light. In order to liberate possible conjugated material it was
made strongly acid with hydrochloric acid and boiled for 1 to 2 minutes (prelimi-
nary investigation had revealed that a considerable amount offluorescent material
502METABOLISM OF PYRENE
Wavelength inm]u.
FIG. 4.-Absorption spectra in ethyl alcohol.
3: 8-dihydroxypyrene - - - - phenol from hydrolysed rat urine.
was destroyed when heating was continued beyond this time). The hydrolysed
urine was then extracted directly with benzene and this dried over sodium sulphate
prior to chromatography on alumina.
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RESULTS
The results obtained from both rats and mice after both intravenous and intra-
peritoneal injections were very similar and will be considered under the same
general headings.
Faeces
The final benzene extract was deep yellow in colour with a strong blue-violet
fluorescence under ultra-violet light. By means of the analytical procedures
described above the following metabolic products were identified on the chromato-
gram:
3-hydroxypyrene
pyrene-3: 8-quinone and pyrene-3: 10-quinone.
That the quinones were present as such in the faeces and had not been formed
from the corresponding dihydroxy compounds on chromatography was estab-
lished as follows:
The benzene extract prior to chromatography was washed several times with
20 per cent sodium hydroxide solution to remove phenolic and acidic material.
The clear yellow coloured, dull blue fluorescent benzene, when examined spectro-
scopically was found to possess the strong absorption above 350 m.t. characteristic
of the quinones. When the benzene was then shaken thoroughly with sodium
hydrosulphite solution the yellow colour was almost completely discharged, the
fluorescence became bright blue and the absorption maxima of the dihydroxy
compounds appeared in the spectrogram. This was verified by chromatography
on alumina when the two quinones appeared on the chromatogram.
The sodium hydroxide washings were acidified, extracted with benzene and
the benzene chromatographed on alumina. 3-Hydroxypyrene only was identified
on the chromatogram.
On heating the alcoholic solution of the 3:10 quinone from rat faeces with
hydrochloric acid a certain amount offree pyrene was obtained in addition to the
expected 3: 10-dihydroxypyrene. The amount was very variable however and
appeared to depend upon the conditions attained during extraction. The spectrum
shown (Fig. 5) is that of an extreme case. Attempts to separate the precursor
from the quinone were unsuccessful so that the possibility of a quinhydrone type
of complex cannot be ruled out.
Urine
The urine prior to extraction possessed a very strong blue-violet fluorescence
in ultra-violet light.
(1) Ether extract at pH 7.-The following metabolites were identified on the
chromatogram:
3-hydroxypyrene and small amounts of the two quinones (possibly formed
from the corresponding diphenols on chromatography).
(2) Ether extract at pH 2.-The benzene extract of the mouse urine possessed
a much stronger blue-violet fluorescence under ultra-violet light than that from
the rat urine and analysis of the chromatogram revealed that this quantitative
difference was due to the presence of further amounts of 3-hydroxypyrene. The
presence of this 3-hydroxypyrene is difficult to explain. Presumably, however,
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FIG. 5.-Absorption spectra in ethyl alcohol.
"quinonoidal complex" from rat faeces. same solution warmed with
a few drops of concentrated hydrochloric acid showing appearance of the absorption peaks
of pyrene.
under warm acidic conditions, it could result from either the hydrolysis of a loose
conjugate of the phenol or the dehydration of a dihydroxy-dihydro compound.
Small amounts of the two quinones were also identified on the chromatogram
but these must have been formed from the diphenols as any free quinone would
have been previously extracted at pH 7.
The filtrate from the chromatogram contained free pyrene so this must have
been liberated during the warm acid conditions of the Soxhlet extraction.
(3) Benzene extract of hydrolysed urine.-The benzene extract was a very
pale yellow in colour with a strong blue-white fluorescence under ultraviolet
light. Direct spectroscopic examination ofthe benzene extract prior to chromato-
graphy suggested that considerable amounts ofthe 3: 8- and the 3: 10-dihydroxy
compounds were present.
The following pyrene derivatives were identified on the chromatogram:
a small amount of 3-hydroxypyrene;
pyrene-3: 8-quinone and pyrene-3: O10-quinone (formed from the corre-
sponding dihydroxy compounds on chromatography).
The liberation of these phenols by heating under strongly acidic conditions
suggests thattheywere originallypresentina conjugated stateandthisissupported
by the findings of Elson, Goulden and Warren (1945) described previously. The
other possibility is that they were formed from dihydroxy-dihydro and tetra-
hydroxy-tetrahydro derivatives. In the case of the diphenols the problem was
resolved as follows.
After extraction with ether atpH 2 almost all the fluorescent material could be
removed by shaking with amyl alcohol. The amyl alcohol was thenyellow in colour
with a strong blue fluorescence. A sample of the amyl alcohol dissolved in ethyl
alcohol and examined spectroscopically showed absorption maxima at 276, 334
and 346 m./u. On heating the mixture with hydrochloric acid these disappeared
and were replaced by the 278, 336 and 352 m./. maxima of 3: 8-dihydroxypyrene.
34§
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Had either of the two tetrahydroxy-tetrahydro compounds been present in the
amyl alcohol extract a naphthalene type spectrum would have been expected.
More direct evidence of conjugation was sought by incubating the extracted
urine, prior to acid hydrolysis, with /-glucuronidase in acetate buffer at pH 5.5.
Under these conditions only small amounts of the free dihydroxy compounds
were liberated so it is possible that the bulk ofthe conjugation is with sulphate.
The filtrate from the chromatogram of the hydrolysed urine again contained
free pyrene presumably formed from a precursor.
The results can be summarised as follows.
Excretion in faeces.-3-Hydroxypyrene, pyrene-3: 10-quinone and pyrene-
3: 8-quinone plus a variable amount of an unidentified "quinonoidal complex"
from rat faeces.
Excretion in urine.-3-Hydroxypyrene: mainly free but possibly conjugated
to a small extent. 3: 10- and 3: 8-dihydroxypyrenes: a little free but mainly
conjugated. An unidentified pyrene precursor.
DISCUSSION
If we refer back to the general conclusions outlined in the introduction then
weseethatthemetabolismofpyrenepossessesfactorswhichare commontoboththe
carcinogenic and non-carcinogenic hydrocarbons. Thus its excretion as free phenol
and quinones is typical of the carcinogenic series whilst the apparent conjugation
ofthe metabolites and the excretion of a small amount of acid-labile hydrocarbon
precursor is indicative of the non-carcinogenic series. In these respects it would
indeed appear to be intermediate between the two. In addition we have the
unique case of the "quinonoidal complex" being excreted in rat faeces.
Perhaps the most significant fact, however, which emerges from the fore-
going study is the coincidence of the sites of biological oxidation with those of
greatest chemical reactivity in the pyrene molecule. Previously it has been held
as a significant fact that metabolic oxidation of the polycyclic hydrocarbons
(with the exception ofphenanthrene) primarily takes place at centres of relatively
low reactivity. In the case ofpyrene, however, not only does oxidation take place
in the most chemically reactive 3-position but in addition we have the unique
case of a second hydroxyl group entering the molecule at points coinciding with
regions of secondary chemical reactivity, that is the 8 and 10 positions.
Although quantitative data was not looked for at this stage it did appear from
observation that the pyrene was very rapidly and very extensively metabolised
compared with, say, the carcinogenic 3: 4-benzpyrene. This rapid metabolism
may well be due to oxidation in these most reactive positions and is possibly a
factor in determining the status of pyrene as a non-carcinogen. Further investi-
gation is to be carried out on the metabolism in tissue. Preliminary work suggests
that, as in the case of 3: 4-benzpyrene, phenols are not the primary metabolites.
SUMMARY
1. After intravenous and intraperitoneal injection in the rat and the mouse,
pyrene is metabolised to a variety of products which are excreted in the urine
and the faeces.
2. In the faeces 3-hydroxypyrene an.d the 3: 10- and the 3: 8-quinones have
been identified. A variable amount of a '" (uinonoidal complex" liberating free
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pyrene anld pyrene-3: lO-quinone on heating with hydrochloric acid has been
isolated from rat faeces but not identified.
3. In the urine the metabolites have beenii identified as 3-hydroxypyrene,
mnainly free but possibly conjugated to a small extent, 3: 8 and 3: 10-dihydroxy-
pyrenes, a little free but mainly conjugated and a small amount of a water soluble
pyrene precursor which liberates the parent hydrocarbon on heating theurinewith
hydrochloric acid.
4. These results are discussed in the light of existing knowledge concerning the
metabolism of the polycyclic hydrocarbons.
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